Literature DB >> 19333752

Absence of the BRCA1 del (exons 9-12) mutation in breast/ovarian cancer families outside of Mexican Hispanics.

Diana Torres, Muhammad U Rashid, Antje Seidel-Renkert, Jeffrey N Weitzel, Ignacio Briceno, Ute Hamann.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19333752     DOI： 10.1007/s10549-009-0383-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  11 in total

1.  Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru.

Authors:  J Abugattas; M Llacuachaqui; Y Sullcahuaman Allende; A Arias Velásquez; R Velarde; J Cotrina; M Garcés; M León; G Calderón; M de la Cruz; P Mora; R Royer; J Herzog; J N Weitzel; S A Narod
Journal:  Clin Genet       Date:  2014-10-28       Impact factor: 4.438

2.  Genomic Disparities in Breast Cancer Among Latinas.

Authors:  Filipa Lynce; Kristi D Graves; Lina Jandorf; Charite Ricker; Eida Castro; Laura Moreno; Bianca Augusto; Laura Fejerman; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

3.  Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

Authors:  Jeffrey N Weitzel; Jessica Clague; Arelis Martir-Negron; Raquel Ogaz; Josef Herzog; Charité Ricker; Chelsy Jungbluth; Cheryl Cina; Paul Duncan; Gary Unzeitig; J Salvador Saldivar; Mary Beattie; Nancy Feldman; Sharon Sand; Danielle Port; Deborah I Barragan; Esther M John; Susan L Neuhausen; Garrett P Larson
Journal:  J Clin Oncol       Date:  2012-12-10       Impact factor: 44.544

4.  Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.

Authors:  Gabriela Torres-Mejía; Robert Royer; Marcia Llacuachaqui; Mohammad R Akbari; Anna R Giuliano; Louis Martínez-Matsushita; Angélica Angeles-Llerenas; Carolina Ortega-Olvera; Elad Ziv; Eduardo Lazcano-Ponce; Catherine M Phelan; Steven A Narod
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-04       Impact factor: 4.254

5.  Clinical significance of large rearrangements in BRCA1 and BRCA2.

Authors:  Thaddeus Judkins; Eric Rosenthal; Christopher Arnell; Lynn Anne Burbidge; Wade Geary; Toby Barrus; Jeremy Schoenberger; Jeffrey Trost; Richard J Wenstrup; Benjamin B Roa
Journal:  Cancer       Date:  2012-04-27       Impact factor: 6.860

6.  Analysis of BRCA1and BRCA2 large genomic rearrangements in Sri Lankan familial breast cancer patients and at risk individuals.

Authors:  Sumadee De Silva; Kamani Hemamala Tennekoon; Eric Hamilton Karunanayake; Indrani Amarasinghe; Preethika Angunawela
Journal:  BMC Res Notes       Date:  2014-06-06

7.  Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients.

Authors:  D Torres; J Lorenzo Bermejo; M U Rashid; I Briceño; F Gil; A Beltran; V Ariza; U Hamann
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

Review 8.  Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines.

Authors:  Marcia Cruz-Correa; Julyann Pérez-Mayoral; Julie Dutil; Miguel Echenique; Rafael Mosquera; Keila Rivera-Román; Sharee Umpierre; Segundo Rodriguez-Quilichini; Maria Gonzalez-Pons; Myrta I Olivera; Sherly Pardo
Journal:  Hered Cancer Clin Pract       Date:  2017-01-21       Impact factor: 2.857

9.  Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.

Authors:  Beth Crawford; Sophie B Adams; Taylor Sittler; Jeroen van den Akker; Salina Chan; Ofri Leitner; Lauren Ryan; Elad Gil; Laura van 't Veer
Journal:  Breast Cancer Res Treat       Date:  2017-03-09       Impact factor: 4.872

10.  A novel method to detect the Mexican founder mutation BRCA1 ex9‑12del associated with breast and ovarian cancer using quantitative polymerase chain reaction and TaqMan® probes.

Authors:  Denisse Aideé Martínez-Treviño; Rafael Baltazar Reyes León-Cachón; Cynthia Villarreal-Garza; Dione Aguilar Y Méndez; Elisa Aguilar-Martínez; Hugo Alberto Barrera-Saldaña
Journal:  Mol Med Rep       Date:  2018-06-06       Impact factor: 2.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.